2016
DOI: 10.1016/j.exer.2016.03.015
|View full text |Cite
|
Sign up to set email alerts
|

Molecular genetics of cone-rod dystrophy in Chinese patients: New data from 61 probands and mutation overview of 163 probands

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
52
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 56 publications
(54 citation statements)
references
References 47 publications
2
52
0
Order By: Relevance
“…In vitro, RDH12 reportedly acts on retinoid substrates with a high affinity toward NADPH and is implicated in detoxification of unsaturated aldehydes produced from lipid peroxidation during oxidative stress (Belyaeva et al 2005; Marchette et al 2010). RDH12 mutations are associated with different types of retinal dystrophies (Gong et al 2015; Huang et al 2016; Zolnikova et al 2016) including Leber congenital amaurosis (LCA), a severe childhood-onset autosomal recessive retinal dystrophy characterized by early visual loss (Janecke et al 2004; Thompson et al 2005; Mackay et al 2011). …”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In vitro, RDH12 reportedly acts on retinoid substrates with a high affinity toward NADPH and is implicated in detoxification of unsaturated aldehydes produced from lipid peroxidation during oxidative stress (Belyaeva et al 2005; Marchette et al 2010). RDH12 mutations are associated with different types of retinal dystrophies (Gong et al 2015; Huang et al 2016; Zolnikova et al 2016) including Leber congenital amaurosis (LCA), a severe childhood-onset autosomal recessive retinal dystrophy characterized by early visual loss (Janecke et al 2004; Thompson et al 2005; Mackay et al 2011). …”
Section: Resultsmentioning
confidence: 99%
“…While its specific cellular substrate remains unknown, RDH12 displays enzymatic activity on both retinoid and sterol substrates in vitro (Keller and Adamski 2007). Mutations in RDH12 have been genetically linked to several different forms of retinal dystrophies including Stargardt disease (Zolnikova et al 2016), cone–rod dystrophy (Huang et al 2016), retinitis pigmentosa (Gong et al 2015), and Leber congenital amaurosis (LCA), which is the most severe form of childhood retinal dystrophy characterized by early visual loss (Janecke et al 2004; Thompson et al 2005; Mackay et al 2011). In addition, disease-associated mutations in RDH12 cofactor-binding domain correspond to accumulation of bioreactive retinoic acid, which can then induce apoptosis in many cells including photoreceptor cells (Lee et al 2007).…”
Section: Introductionmentioning
confidence: 99%
“…For this reason, a more robust approach to clinical diagnosis that is best achieved with targeted panel testing of all known IRD genes as the standard of care is recommended (Neveling et al 2013;Consugar et al 2014). RDH12 mutations can cause a spectrum of retinal degenerations including LCA, CORD, autosomal recessive, autosomal dominant RP, and now macular dystrophy (MD) (Janecke et al 2004;Perrault et al 2004;Fingert et al 2008;Chacon-Camacho et al 2013;Huang et al 2016). For this reason, we suggest gene-specific nomenclature rather than a phenotypic-based approach that may be misleading due to some retinal diseases overlap with multiple genes.…”
Section: Discussionmentioning
confidence: 99%
“…RDH12-associated disease is thought to account for up to 4% of LCA cases (Perrault et al 2004). Subsequently, mutations in RDH12 have been found in patients with autosomal recessive (AR) retinitis pigmentosa (RP) as well as cone-rod dystrophies (CORDs) (Janecke et al 2004;Chacon-Camacho et al 2013;Huang et al 2016). Characteristics of disease caused by recessive biallelic mutations in RDH12 include early-onset progressive degeneration of both rods and cones with severely reduced or extinguished responses on electroretinogram (ERG) (Schuster et al 2007).…”
Section: Introductionmentioning
confidence: 99%
“…Of note, light sensitivity may be one major symptom in patients with variants in CACNA1F , CABP4 , and CACNA2D4 in addition to phenotypic variability sometimes leading to more progressive IRD and thus the term icCSNB may be misleading (reviewed in Zeitz et al, ). More than 150 different variants in CACNA1F and only a few in CABP4 and CACNA2D4 lead to icCSNB or similar phenotypes (reviewed and summarized in 2015 in Zeitz et al, ; additional publications since then, Ba‐Abbad et al, ; Hove et al, ; X. F. Huang et al, ; L. Huang et al, ; Patel et al, ; Sun et al, ; Xu et al, ; Zhao et al, ; Q. Zhou et al, ). The pathogenic variant spectrum comprises missense, nonsense, and splice‐site variants, small insertions and deletions, gross deletions, and complex rearrangements with most of the variants representing missense or nonsense variants (HGMD_Pro; Stenson et al, ; Zeitz et al, ).…”
Section: Introductionmentioning
confidence: 99%